BAX (STOCKS)
Baxter International Inc.
$17.700000
+0.550000 (+3.21%)
Prev close: $17.150000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Andrew P. Hider
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $9,093.80M
- Employees
- 38,000
- P/E (TTM)
- -10.50
- P/B (TTM)
- 1.44
- Dividend Yield
- 209.91%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
4
Buy
16
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.44 | $0.54 | -0.1014 | -18.73% |
|
Sep 2025 (Q3)
|
$0.69 | $0.60 | +0.0856 | +14.16% |
|
Jun 2025 (Q2)
|
$0.59 | $0.62 | -0.0262 | -4.25% |
|
Mar 2025 (Q1)
|
$0.55 | $0.49 | +0.0622 | +12.75% |
Financial Statements
| Revenues | $11.24B |
| Benefits Costs and Expenses | $11.75B |
| Cost Of Revenue | $7.87B |
| Costs And Expenses | $11.75B |
| Gross Profit | $3.38B |
| Operating Expenses | $3.69B |
| Selling, General, and Administrative Expenses | $2.89B |
| Research and Development | $518.00M |
| Other Operating Expenses | $279.00M |
| Operating Income/Loss | -$308.00M |
| Income/Loss From Continuing Operations After Tax | -$900.00M |
| Income/Loss From Continuing Operations Before Tax | -$505.00M |
| Income/Loss From Discontinued Operations Net Of Tax | -$57.00M |
| Income Tax Expense/Benefit | $395.00M |
| Income Tax Expense/Benefit, Current | $318.00M |
| Income Tax Expense/Benefit, Deferred | $77.00M |
| Interest Expense, Operating | $290.00M |
| Net Income/Loss | -$957.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$957.00M |
| Net Income/Loss Available To Common Stockholders, Basic | -$957.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.87 |
| Diluted Earnings Per Share | -$1.87 |
| Basic Average Shares | 513,000,000 |
| Diluted Average Shares | 513,000,000 |
| Assets | $20.06B |
| Current Assets | $6.87B |
| Inventory | $2.23B |
| Other Current Assets | $4.64B |
| Noncurrent Assets | $13.18B |
| Fixed Assets | $2.91B |
| Intangible Assets | $4.37B |
| Other Non-current Assets | $5.90B |
| Liabilities | $13.95B |
| Current Liabilities | $2.97B |
| Accounts Payable | $999.00M |
| Wages | $397.00M |
| Other Current Liabilities | $1.57B |
| Noncurrent Liabilities | $10.98B |
| Long-term Debt | $9.44B |
| Other Non-current Liabilities | $1.55B |
| Equity | $6.10B |
| Equity Attributable To Noncontrolling Interest | -$27.00M |
| Equity Attributable To Parent | $6.13B |
| Liabilities And Equity | $20.06B |
| Net Cash Flow From Operating Activities | $845.00M |
| Net Cash Flow From Operating Activities, Continuing | $951.00M |
| Net Cash Flow From Operating Activities, Discontinued | -$106.00M |
| Net Cash Flow From Investing Activities | $2.84B |
| Net Cash Flow From Investing Activities, Continuing | -$464.00M |
| Net Cash Flow From Investing Activities, Discontinued | $3.31B |
| Net Cash Flow From Financing Activities | -$4.22B |
| Net Cash Flow From Financing Activities, Continuing | -$4.22B |
| Net Cash Flow | -$530.00M |
| Net Cash Flow, Continuing | -$3.73B |
| Net Cash Flow, Discontinued | $3.20B |
| Comprehensive Income/Loss | -$701.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$701.00M |
| Other Comprehensive Income/Loss | $256.00M |
| Other Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |